Tower Research Capital (TRC)’s HealthCor Catalio Acquisition Corp. Class A Ordinary Shares HCAQ Stock Holding History

Tower Research Capital (TRC)’s Portfolio HCAQ Stock Details HCAQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,833	Closed	-$18K	–	7009
2021 Q3	$18K	Buy	1,833 +1,601	+690%	+$15.8K	﹤0.01%	3849
2021 Q2	$2K	Buy	232 +100	+76%	+$989	﹤0.01%	5139
2021 Q1	$1K	Buy	+132	New	+$1.35K	﹤0.01%	5304

Tower Research Capital (TRC)'s HCAQ Position: Q4 2021 in Review

Tower Research Capital (TRC) sold out of HealthCor Catalio Acquisition Corp. Class A Ordinary Shares (HCAQ) in Q4 2021, closing a stake of 1,833 shares — an estimated $18K sold.

Tower Research Capital (TRC) first reported a position in HCAQ in Q1 2021 and held it in 3 quarters. The position peaked at $18K in Q3 2021. 0 funds tracked by Wall St. Rank hold HCAQ as of Q4 2021.

Tower Research Capital (TRC) reported no remaining HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position as of Q4 2021 after selling out during the quarter.
Tower Research Capital (TRC) sold 1,833 HealthCor Catalio Acquisition Corp. Class A Ordinary Shares shares in Q4 2021, an estimated $18K.
Tower Research Capital (TRC) first reported a position in HealthCor Catalio Acquisition Corp. Class A Ordinary Shares in Q1 2021 and held it in 3 quarters.
Tower Research Capital (TRC)'s HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position peaked at $18K in Q3 2021.
0 funds tracked by Wall St. Rank held HealthCor Catalio Acquisition Corp. Class A Ordinary Shares as of Q4 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.